- Knowledge Base
- Guides
- Glossary
- Q&A
- Documentation
- Blog
- For Small Business
- For Capture Teams
- Compare Platforms
- Services
- Workflow Automation
- Support
- Contact Us
© Copyright 2026 Gov Contract Finder.
This federal contract opportunity has been awarded to on September 30, 2025.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF awarded this contract to for $186,004,780 on September 30, 2025, as part of federal procurement initiatives.
This award is part of federal acquisition procurement activities.
This award is for the development of a concentrated Tranexamic Acid (TXA) Intramuscular Injection. The Government seeks this development in order to receive FDA approval for the concentrated IM TXA formulation that can be delivered in a pref-filled syringe or a dedicated autoinjector. This contract action was awarded competitively as a Cost Share Contract. A Cost Share Contract was used in accordance with FAR 35.006 (c) due to an absence of precise specifications and difficulties in estimating costs with accuracy.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in biotechnology (except nanobiotechnology) in WASHINGTON, DC.
Looking for more opportunities?
Browse our full directory of government contracts